Nigrostriatal dopaminergic pathway

The nigrostriatal dopaminergic pathway is a major neural circuit in the brain that connects the substantia nigra pars compacta (SNc) in the midbrain to the dorsal striatum, comprising the caudate nucleus and putamen [Wikipedia, 2024]. As one of the four primary dopaminergic pathways, it is essential for the regulation of voluntary movement and motor planning via the basal ganglia motor loop [NIH, 2024]. In this circuit, dopaminergic neurons release dopamine into the striatum, where it acts on D1-like and D2-like receptors to facilitate or inhibit motor output [ResearchGate, 2021]. The progressive degeneration of these dopaminergic neurons is the primary pathological feature of Parkinson's disease, resulting in motor deficits such as bradykinesia, resting tremors, and postural instability [NIH, 2024]. Pharmacological interventions, such as levodopa and dopamine agonists, aim to restore dopaminergic tone within this circuitry to alleviate symptoms [StatPearls, 2023]. However, long-term treatment often leads to complications like levodopa-induced dyskinesia and motor fluctuations [NIH, 2024]. Beyond motor control, the nigrostriatal pathway is also implicated in reward-related learning and the pathophysiology of certain psychiatric disorders [Harvard, 2024].

Other names

Nigrostriatal pathwayNigrostriatal tractMesostriatal pathwayNigrostriatal systemNigrostriatal dopaminergic circuitry

Pharmacological modulation involves dopamine replacement, dopamine receptor agonism, inhibition of dopamine degradation (via MAO-B or COMT inhibitors), and dopamine receptor antagonism.